{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:28:08Z","timestamp":1761488888734,"version":"3.38.0"},"reference-count":116,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T00:00:00Z","timestamp":1332806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Urology"],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:p> Many patients with advanced genitourinary malignancies develop bone metastases, which can lead to potentially debilitating skeletal complications. Moreover, age-related bone loss and cancer treatments such as hormonal therapy for prostate cancer can weaken bone, placing patients at risk for osteoporotic fractures in addition to skeletal-related events (SREs) from bone metastases. Zoledronic acid, a bisphosphonate, is approved worldwide to reduce the risk of SREs in patients with bone metastases from solid tumors or bone lesions from multiple myeloma. Zoledronic acid, although underutilized in genitourinary malignancies, has long been the mainstay of treatment in patients with bone metastases, and can also help preserve bone during anticancer therapy. Recently, denosumab, a monoclonal antibody directed against the receptor activator of nuclear factor kappa-B ligand, was approved in the United States and the European Union for reducing the risk of SREs in patients with bone metastases from solid tumors. Denosumab (at a lower dose) is also approved in the European Union and the United States to treat androgen deprivation-induced bone loss in men with prostate cancer. In addition, preclinical rationale and emerging clinical data suggest that bone-modifying agents may be able to delay disease progression in genitourinary cancers, just as newly developed anticancer treatments have produced reductions in SREs, possibly by indirect effects on the disease course. This review article summarizes current data and ongoing studies to preserve bone health in patients with advanced genitourinary cancers. <\/jats:p>","DOI":"10.1177\/1756287212441234","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T15:34:35Z","timestamp":1332862475000},"page":"85-101","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: a focus on zoledronic acid"],"prefix":"10.1177","volume":"4","author":[{"given":"Matti","family":"Aapro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,3,27]]},"reference":[{"key":"bibr1-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm442"},{"journal-title":"Cancer Treat Rev","year":"2011","author":"Aapro M.","key":"bibr2-1756287212441234"},{"key":"bibr3-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-9056(08)60642-9"},{"key":"bibr4-1756287212441234","unstructured":"Amgen Europe B.V. (2010) Prolia [summary of product characteristics]. Amgen Europe B.V.: Breda, The Netherlands."},{"key":"bibr5-1756287212441234","unstructured":"Amgen Inc. (2010) Xgeva (denosumab) injection [package insert]. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/125320s007lbl.pdf. Amgen Inc.: Thousand Oaks, CA."},{"key":"bibr6-1756287212441234","unstructured":"Amgen Inc. (2011) Xgeva (denosumab) granted marketing authorization in the European Union [press release]. Available at: http:\/\/www.amgen.com\/media\/media_pr_detail.jsp?releaseID=1585714. Amgen Inc.: Thousand Oaks, CA."},{"issue":"15","key":"bibr7-1756287212441234","first-page":"353s","volume":"28","author":"Anand A.","year":"2010","journal-title":"J Clin Oncol"},{"key":"bibr8-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.06.001"},{"key":"bibr9-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.03.017"},{"key":"bibr10-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22488"},{"key":"bibr11-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.07.046"},{"volume-title":"Poster session presented at: The IX International Meeting on Cancer Induced Bone Disease","year":"2009","author":"Body J.-J.","key":"bibr12-1756287212441234"},{"key":"bibr13-1756287212441234","first-page":"2949","volume":"60","author":"Boissier S.","year":"2000","journal-title":"Cancer Res"},{"key":"bibr14-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1038\/nature01658"},{"key":"bibr15-1756287212441234","unstructured":"British Association of Urological Surgeons. (2005) Metastatic Prostate Cancer Guidelines. London, UK: The British Association of Urological Surgeons. http:\/\/www.echurology.co.uk\/baus.html."},{"key":"bibr16-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji002"},{"volume-title":"Poster session presented at: American Society of Clinical Oncology 2009 Genitourinary Cancers Symposium","year":"2009","author":"Brown J.E.","key":"bibr17-1756287212441234"},{"key":"bibr18-1756287212441234","first-page":"5170","volume":"17","author":"Casey R.","year":"2010","journal-title":"Can J Urol"},{"key":"bibr19-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08972.x"},{"key":"bibr20-1756287212441234","doi-asserted-by":"publisher","DOI":"10.2174\/138161210793563545"},{"key":"bibr21-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399408000616"},{"key":"bibr22-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-1106-6"},{"key":"bibr23-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.2000.0210"},{"key":"bibr24-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.091"},{"key":"bibr25-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0269"},{"volume-title":"Poster session presented at: The IX International Meeting on Cancer Induced Bone Disease","year":"2009","author":"Costa L.","key":"bibr26-1756287212441234"},{"key":"bibr27-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-4096.2004.04831.x"},{"key":"bibr28-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68000-7"},{"issue":"15","key":"bibr29-1756287212441234","first-page":"375s","volume":"28","author":"Danila D.C.","year":"2010","journal-title":"J Clin Oncol"},{"key":"bibr30-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1506"},{"key":"bibr31-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014618"},{"key":"bibr32-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70201-3"},{"volume-title":"Oral session presented at: American Society of Clinical Oncology 2009 Genitourinary Cancers Symposium","year":"2009","author":"Dearnaley D.P.","key":"bibr33-1756287212441234"},{"key":"bibr34-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0199"},{"issue":"9","key":"bibr35-1756287212441234","first-page":"ix156","volume":"17","author":"Donat D.A.","year":"2006","journal-title":"Ann Oncol"},{"key":"bibr36-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.042"},{"key":"bibr37-1756287212441234","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.10.6.12611"},{"key":"bibr38-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62344-6"},{"key":"bibr39-1756287212441234","unstructured":"Garcia M., Jemal A., Ward E.M., Center M., Hao Y., Siegel R.L. (2007) Global cancer facts and figures 2007. Available at: http:\/\/www.cancer.org\/acs\/groups\/content\/@nho\/documents\/document\/globalfactsandfigures2007rev2p.pdf. Atlanta, GA: American Cancer Society."},{"key":"bibr40-1756287212441234","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-5-200703060-00005"},{"key":"bibr41-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2008.03.006"},{"key":"bibr42-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.535511"},{"key":"bibr43-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23775"},{"key":"bibr44-1756287212441234","unstructured":"Heidenreich A., Bolla M., Joniau S., van der Kwast T.H., Matveev V., Mason M.D. (2009) Guidelines on prostate cancer. Available at: http:\/\/www.uroweb.org\/fileadmin\/tx_eauguidelines\/2009\/Full\/Prostate_Cancer.pdf. Arnhem, The Netherlands: European Association of Urology."},{"volume-title":"Poster session presented at: 2005 American Society of Clinical Oncology Prostate Cancer Symposium","year":"2005","author":"Heidenreich A.","key":"bibr45-1756287212441234"},{"key":"bibr46-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.3304"},{"key":"bibr47-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-55382003000300006"},{"key":"bibr48-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2008.9846"},{"key":"bibr49-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080205"},{"key":"bibr50-1756287212441234","doi-asserted-by":"publisher","DOI":"10.3816\/CGC.2007.n.003"},{"key":"bibr51-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.01.046"},{"key":"bibr52-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2009.11.016"},{"key":"bibr53-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.08124.x"},{"key":"bibr54-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0441"},{"key":"bibr55-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.02.153"},{"key":"bibr56-1756287212441234","doi-asserted-by":"publisher","DOI":"10.3816\/CGC.2009.n.029"},{"key":"bibr57-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22904"},{"key":"bibr58-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2008.09.012"},{"issue":"15","key":"bibr59-1756287212441234","first-page":"271s","volume":"27","author":"Lee R.J.","year":"2009","journal-title":"J Clin Oncol"},{"key":"bibr60-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23529"},{"volume-title":"Poster session presented at: What Is New in Bisphosphonates? Seventh Workshop on Bisphosphonates\u2014From the Laboratory to the Patient","year":"2004","author":"Lipton A.","key":"bibr61-1756287212441234"},{"key":"bibr62-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-120014886"},{"key":"bibr63-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11571"},{"key":"bibr64-1756287212441234","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.4520","volume":"29","author":"Logothetis C.","year":"2011","journal-title":"J Clin Oncol"},{"key":"bibr65-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-2223"},{"key":"bibr66-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.8.8782"},{"key":"bibr67-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyp122"},{"key":"bibr68-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-S2-45"},{"key":"bibr69-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1080\/02841860600996447"},{"key":"bibr70-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1754"},{"volume-title":"Oral session presented at: 22nd Annual EAU Congress","year":"2007","author":"Mulders P.F.","key":"bibr71-1756287212441234"},{"key":"bibr72-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1038\/nrc867"},{"key":"bibr73-1756287212441234","doi-asserted-by":"publisher","DOI":"10.3727\/096504010X12671222663638"},{"key":"bibr74-1756287212441234","unstructured":"National Comprehensive Cancer Network. (2009) NCCN clinical practice guidelines in oncology: prostate cancer, v.2.2009. Available at: http:\/\/www.nccn.org. Fort Washington, PA: National Comprehensive Cancer Network, Inc."},{"key":"bibr75-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20602"},{"key":"bibr76-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02583-9"},{"key":"bibr77-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1038\/nm0806-875"},{"key":"bibr78-1756287212441234","unstructured":"Novartis Pharmaceuticals Corporation. (2011) Zometa\u00ae (zoledronic acid) injection [package insert]. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/021386s004lbl.pdf. East Hanover, NJ: Novartis Pharmaceuticals Corporation."},{"key":"bibr79-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn544"},{"volume-title":"Poster session presented at: 24th Annual Meeting of the American Society for Bone and Mineral Research","year":"2002","author":"Padalecki S.S.","key":"bibr80-1756287212441234"},{"key":"bibr81-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)49915-0"},{"key":"bibr82-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05441.x"},{"key":"bibr83-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08622.x"},{"key":"bibr84-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500599"},{"key":"bibr85-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn526"},{"key":"bibr86-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500752"},{"key":"bibr87-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L"},{"key":"bibr88-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20308"},{"key":"bibr89-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.105"},{"key":"bibr90-1756287212441234","first-page":"907","volume":"2","author":"Rucci N.","year":"2010","journal-title":"Front Biosci (Schol Ed)"},{"key":"bibr91-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.04.078"},{"key":"bibr92-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2007.10.002"},{"key":"bibr93-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.06.007"},{"key":"bibr94-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.06.001"},{"key":"bibr95-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.19.1458"},{"key":"bibr96-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh141"},{"key":"bibr97-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05740.x"},{"key":"bibr98-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22991"},{"volume-title":"Oral session presented at: 2011 ASCO Annual Meeting","year":"2011","author":"Scher H.I.","key":"bibr99-1756287212441234"},{"key":"bibr100-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.48"},{"key":"bibr101-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.147"},{"key":"bibr102-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0846"},{"key":"bibr103-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.03.071"},{"key":"bibr104-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000063820.94994.95"},{"key":"bibr105-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809003"},{"key":"bibr106-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010845"},{"key":"bibr107-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61226-9"},{"issue":"2","key":"bibr108-1756287212441234","first-page":"933","volume":"28","author":"Soltau J.","year":"2008","journal-title":"Anticancer Res"},{"key":"bibr109-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09329.x"},{"key":"bibr110-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1080\/00365590802475904"},{"key":"bibr111-1756287212441234","unstructured":"US National Institutes of Health (2009) RADAR trial\u2014randomized androgen deprivation and radiotherapy. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00193856."},{"key":"bibr112-1756287212441234","unstructured":"US National Institutes of Health (2011a) Study on prolonging bone metastasis-free survival in men with hormone refractory prostate cancer. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00286091."},{"key":"bibr113-1756287212441234","unstructured":"US National Institutes of Health (2011b) Zoledronate plus standard therapy compared with placebo plus standard therapy to prevent bone metastases in patients with recurrent prostate cancer that has no symptoms. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00005073."},{"key":"bibr114-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.0563"},{"key":"bibr115-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0571-9"},{"key":"bibr116-1756287212441234","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-010-0074-5"}],"container-title":["Therapeutic Advances in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1756287212441234","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1756287212441234","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1756287212441234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T11:20:55Z","timestamp":1741000855000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1756287212441234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.1177\/1756287212441234"],"URL":"https:\/\/doi.org\/10.1177\/1756287212441234","relation":{},"ISSN":["1756-2872","1756-2880"],"issn-type":[{"type":"print","value":"1756-2872"},{"type":"electronic","value":"1756-2880"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}